Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Pain · Hyponatremia · CPIX

Cumberland Pharmaceuticals

CUMBERLAND PHARMACEUTICALS INC

Cumberland Pharmaceuticals trial registry — 64 ClinicalTrials.gov studies with program phase, status, and indication context.

Website Investor relations
1600 W End Ave, #1300, Nashville, Tennessee 37203, US HQ
1999 Founded
128 Employees
Public company Type
CPIX · NYSE Ticker
Company details
Status
Public
HQ
1600 W End Ave, #1300, Nashville, Tennessee 37203, US
Founded
1999
Employees
128
Programs
53
Drugs
26
Patents
34
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Trials

Cumberland Pharmaceuticals clinical trials

Registry index of 64 ClinicalTrials.gov studies linked to Cumberland Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Cumberland Pharmaceuticals trial registry — 64 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Cumberland Pharmaceuticals.

  1. Telavancin Injection — Approved

    Clinical update

  2. Telavancin Injection — Approved

    Clinical update

  3. Telavancin — Phase 3

    Clinical update

  4. Ofirmev — Approved

    Clinical update

  5. N-Acetylcysteine (NAC) — Phase 2

    Clinical update

  6. lactulose (Kristalose®) — Approved

    Clinical update

  7. IV ibuprofen — Approved

    Clinical update

  8. Intravenous ibuprofen — Phase 3

    Clinical update

Trial registry

64 studies

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.